Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

DR info

Clinical trials : 454 / Drugs : 430 - (DrugBank : 90) / Drug target genes : 66 - Drug target pathways : 183

Other names

Disease group

Metabolic diseases

Domestic patients
Med expenses recipients, FY2024 (corrected) (in Japanese)

8,169 patients

Age distribution

💬

Clinical research form (in Japanese)
MHLW Intractable Diseases, FY2026 (in Japanese)

Overview, diagnostic criteria, etc. (pdf), Notice（R7.1.16） (pdf), Notice（R7.8.21） (pdf), Clinical research form (pdf) 028-01, 028-02, 028-03, 028-04

Specific pediatric chronic diseases, Japan (in Japanese)

2-5-25. Amyloid nephropathy

Sub-diseases
(Clinical research forms may not be available for all sub-diseases.)

No.

Name

Specific pediatric chronic diseases, Japan (in Japanese)

28-1.

Immunoglobulin light chain amyloidosis;Amyloid light-chain amyloidosis;AL amyloidosis;Immunoglobulin light chain amyloidosis;Immunoglobulin-related amyloidosis;Amyloid heavy-chain amyloidosis;Amyloid heavy-chain amyloidosis;AH amyloidosis;

28-2.

Systemic wild-type transthyretin amyloidosis;Senile systemic amyloidosis;SSA;Transthyretin amyloid cardiomyopathy;ATTR-CM;

28-3.

Hereditary transthyretin amyloidosis;Familial amyloidosis;Familial amyloid polyneuropathy;FAP;Transthyretin amyloid cardiomyopathy;ATTR-CM;

28-4.

Hereditary systemic amyloidosis;